Paul Tudor Jones II's position in Target is currently worth $4.39 Million. That's 0.05% of their equity portfolio (437th largest holding). The first Target trade was made in Q4 2013. Since then Paul Tudor Jones II bought shares 38 more times and sold shares on 38 occasions. The investor's estimated purchase price is $6.91 Million, resulting in a loss of 37%.
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Biogen (BIIB) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to...
Related Stocks: ANTM , TGT , CL , MCK , GS , BIIB , MRNA , KSS , SBUX , ZBRA , IPG , MMM , PG , LLY , HON , ADSK , MRK , HLT , MO , BBY , ODFL , HUM , HPQ , ...
Related Stocks: ESGU , SUSB , SUSC , NUSC , NUHY , IBHD , ACWF , IUSB , IBDN , IBDO , SGOV , IBTD , AGG , TGT , PFE , QQQ , VTRS , MBII ,